tradingkey.logo
tradingkey.logo
Suchen

iSpecimen Inc

ISPC
Zur Watchlist hinzufügen
2.640USD
-0.090-3.30%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
48.94KMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über iSpecimen Inc Unternehmen

iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.

iSpecimen Inc Informationen

BörsenkürzelISPC
Name des UnternehmensiSpecimen Inc
IPO-datumJun 17, 2021
CEOField (Katharyn)
Anzahl der mitarbeiter24
WertpapierartOrdinary Share
GeschäftsjahresendeJun 17
Addresse8 Cabot Road
StadtWOBURN
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl08101
Telefon17813016700
Websitehttps://www.ispecimen.com/
BörsenkürzelISPC
IPO-datumJun 17, 2021
CEOField (Katharyn)

Führungskräfte von iSpecimen Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von iSpecimen Inc?

Die fünf größten Anteilseigner von iSpecimen Inc sind: Mr. Avtar Dhaliwal

Wie viele Institutionen halten Anteile an iSpecimen Inc (ISPC)?

Mit Stand vom 2026Q1 halten 31 Institutionen Anteile an iSpecimen Inc, mit einem Gesamtmarktwert von etwa 5.11K, was 0.39% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -79730.00 gestiegen.

Was ist die größte Einnahmequelle von iSpecimen Inc?

Am 2026Q1 erzielte das Geschäft mit Specimens – contracts with customers für iSpecimen Inc den höchsten Umsatz in Höhe von 95.82K, was 89.89% des Gesamtumsatzes entspricht.